닥플 플러스
[Day2] 2026 KPS in conjunction with APSU Joint International Symposium
대한전립선학회
연수평점 :5점
오프라인
주관
대한전립선학회
교육일자
2026-09-12
수강료
30,000원
교육형태
오프라인
등록일시
2026-08-05
교육시간
5시간 10분
연수평점
5점
장소
인천광역시 송도 컨벤시아 그랜드볼룸 B,C
교육종류
비뇨의학과, 의사학, 의료사회학, 의료정책
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-09-12 | 09:10~09:30 | Liquid Biopsy in Prostate Cancer: Current Clinical Applications and Future Perspectives | Fumihiko URABE (Japan)(Jikei University) | - |
| 2026-09-12 | 09:30~09:50 | Gut Microbiome and Prostate Cancer | Vincent Fradet (Canada) (Université Laval) | - |
| 2026-09-12 | 09:50~10:05 | PSMA PET/CT after Equivocal MRI: Can We Halve Unnecessary Biopsies? (PRIMARY2 RCT) | 최세민(경상의대) | - |
| 2026-09-12 | 10:05~10:20 | Transperineal vs Transrectal Biopsy updates: TRANSLATE Trial | 신택준(계명의대) | - |
| 2026-09-12 | 10:20~10:25 | Case-based Panel Discussion | 이종수(연세의대) | - |
| 2026-09-12 | 10:25~10:50 | Coffee Break | - | - |
| 2026-09-12 | 10:50~11:05 | UTUC & Synchronous Bladder Cancer: Staging, Sequencing & Treatment Strategies — Taiwan Experience | Shian-Shiang WANG (Taiwan) (Taichung Veterans General Hospital) | - |
| 2026-09-12 | 11:05~11:20 | FGFR-targeted Therapy in NMIBC: Intravesical Erdafitinib (TAR-210) & Oral Dabogratinib (SURF302) | 박태영(가천의대 ) | - |
| 2026-09-12 | 11:20~11:35 | Neoadjuvant & Perioperative Therapy for MIBC : EV+Pembrolizumab (KEYNOTE-B15) & NIAGARA (Durvalumab+GemCis) | 권세윤(동국의대) | - |
| 2026-09-12 | 11:35~11:50 | Bladder Preservation After NAC in MIBC: Cystectomy vs. Organ-sparing Approaches | 남종길(부산의대) | - |
| 2026-09-12 | 11:50~11:55 | Case-based Panel Discussion | 윤성구(한양의대) | - |
| 2026-09-12 | 11:55~12:10 | KPS BLUE Award | 정재영(국립암센터) | - |
| 2026-09-12 | 12:10~12:30 | Navigating mHSPC : Clinical evidence supporting the efficacy of Apalutamide | 최세영(중앙의대) | - |
| 2026-09-12 | 12:30~13:20 | Lunch | - | - |
| 2026-09-12 | 13:20~13:40 | Current status and challenges in mCRPC treatment | Hiroji UEMURA (Japan)(Yokohama City Univ.) | - |
| 2026-09-12 | 13:40~14:00 | Can We Predict Treatment Response in Prostate Cancer?Patient-derived Organoids & Treatment Response Prediction | Su Jung Oh-Hohenhorst (Germany) (Univ. Medical Center Hamburg-Eppendorf (UKE)) | - |
| 2026-09-12 | 14:00~14:20 | Emerging Therapies in mCRPC: T Cell Engagers, ADCs and Bifunctional Proteins | Joseph W KIM (USA)(Yale School of Medicine) | - |
| 2026-09-12 | 14:20~14:40 | Case-based Panel Discussion | 신동호(가톨릭의대) | - |
| 2026-09-12 | 14:40~15:00 | Coffee Break | - | - |
| 2026-09-12 | 15:00~15:15 | Beyond the Standard: Shaping the New Era of BPH Surgery with MIST (UroLIFT, Rezum, iTind) | 안지훈(목포시의료원) | - |
| 2026-09-12 | 15:15~15:30 | HoLEP in 2026: Who Should Still Be Doing It and How to Optimize Results | 이충렬(충남의대) | - |
| 2026-09-12 | 15:30~15:45 | Robot Simple Prostatectomy — Approach, Urethral Reconstruction & Outcomes in Large Glands | 박태용(성균관의대) | - |
| 2026-09-12 | 15:45~16:00 | Post-operative Voiding Dysfunction and Detrusor Underactivity after BPH Surgery | 류호영(이화의대) | - |
| 2026-09-12 | 16:00~16:10 | Case-based Panel Discussion | 류재현(중앙보훈병원) | - |
| 2026-09-12 | 16:10~16:50 | Best Abstract Prize Ceremony & Closing Remarks | 정재영(국립암센터) | - |
비고
현장등록 : 전문의 40,000 원 , 연구원,간호사,전공의,학생 : 무료
문의처
담당자
이명철
연락처
02-6956-7967
이메일
gaonpco@gaonpco.com